# Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand

> **NCT02293564** · NA · COMPLETED · sponsor: **XOMA (US) LLC** · enrollment: 312 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** gevokizumab

## Key facts

- **NCT ID:** NCT02293564
- **Lead sponsor:** XOMA (US) LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2015-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293564, "Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the Hand". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02293564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*